Skip to main content
EKF DIAGNOSTICS HOLDINGS PLC logo

EKF DIAGNOSTICS HOLDINGS PLC — Investor Relations & Filings

Ticker · EKF ISIN · GB0031509804 LEI · 213800DXTF3EAUK1AR05 IL Manufacturing
Open in API
Filings indexed 504 across all filing types
Latest filing 2025-04-09 Transaction in Own Shar…
Country GB United Kingdom
Listing IL EKF

About EKF DIAGNOSTICS HOLDINGS PLC

https://www.ekfdiagnostics.com/

EKF Diagnostics Holdings plc is a global in-vitro diagnostics (IVD) and biotechnology company that develops, manufactures, and distributes medical technologies. The company provides solutions for both point-of-care (POC) and central laboratory settings. Its product portfolio includes a range of analyzers, reagents, and tests for critical parameters such as hemoglobin, HbA1c, glucose, and lactate, which are used for the early detection, diagnosis, and monitoring of various conditions. EKF also offers products for life sciences applications, supporting therapeutic development and high-throughput analysis. The company is focused on delivering reliable, accurate, and cost-effective diagnostic tools to empower healthcare professionals and enhance patient outcomes.

Recent filings

Filing Released Lang Actions
Share Buyback
Transaction in Own Shares Classification · 1% confidence The document is an official announcement from EKF Diagnostics Holdings PLC regarding a share buyback program. It details the number of shares purchased, the price paid, and the impact on total voting rights. It also includes a mandatory disclosure of a transaction by a Person Discharging Managerial Responsibilities (PDMR), specifically a Non-Executive Director. While it contains PDMR dealing information, the primary purpose of the filing is the announcement of the company's own share repurchase (buyback). According to the provided definitions, 'Transaction in Own Shares' (POS) is the most specific and accurate category for company share buybacks.
2025-04-09 English
Share Buyback
Transaction in Own Shares Classification · 1% confidence The document is an official announcement from EKF Diagnostics Holdings PLC regarding a share buyback program. It details the purchase of 500,000 ordinary shares, provides a breakdown of the transaction, and includes a mandatory PDMR (Person Discharging Managerial Responsibilities) notification regarding a director's disposal of shares as part of this buyback. While it contains PDMR information, the primary purpose of the filing is to report the company's transaction in its own shares (share repurchase). Therefore, it is classified as a Transaction in Own Shares (POS).
2025-04-08 English
Share Buyback
Transaction in Own Shares Classification · 1% confidence The document is an official announcement from EKF Diagnostics Holdings PLC regarding a share buyback program. It details the purchase of ordinary shares to be held in treasury and includes a PDMR (Person Discharging Managerial Responsibilities) dealing disclosure regarding a director's disposal of shares as part of this buyback. While it contains PDMR information, the primary corporate action is the company's repurchase of its own shares, which falls under the 'Transaction in Own Shares' category.
2025-04-07 English
Share Buyback
Transaction in Own Shares Classification · 1% confidence The document is an official announcement from EKF Diagnostics Holdings PLC regarding a share buyback program. It details the number of shares purchased, the price paid, and the impact on total voting rights. Additionally, it includes a mandatory disclosure of a transaction by a Person Discharging Managerial Responsibilities (PDMR), specifically a Non-Executive Director. While it contains PDMR information, the primary purpose of the filing is the company's repurchase of its own shares, which aligns with the 'Transaction in Own Shares' (POS) category.
2025-04-07 English
Share Buyback
Transaction in Own Shares Classification · 1% confidence The document is an official announcement from EKF Diagnostics Holdings PLC regarding a share buyback program. It details the purchase of ordinary shares to be held in treasury, provides transaction specifics (price, volume, venue), and includes a mandatory PDMR (Person Discharging Managerial Responsibilities) dealing disclosure. Since the primary purpose is to report the company's repurchase of its own shares, it falls under the 'Transaction in Own Shares' category.
2025-04-02 English
Share Buyback
Transaction in Own Shares Classification · 1% confidence The document is an official announcement from EKF Diagnostics Holdings plc regarding a share buyback program. It details the purchase of 700,000 ordinary shares to be held in treasury, provides transaction breakdowns, and includes a mandatory PDMR (Person Discharging Managerial Responsibilities) dealing notification for a director, Christopher Mills. While it contains director dealing information, the primary purpose of the filing is the company's own share repurchase activity, which falls under the 'Transaction in Own Shares' category.
2025-04-01 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.